Immunic Inc. (IMUX) PT Raised to $61 at BMO Capital, Following Drug Trial Results

Go back to Immunic Inc. (IMUX) PT Raised to $61 at BMO Capital, Following Drug Trial Results
(NASDAQ: IMUX) Delayed: 10.83 +0.21 (1.98%)
Previous Close $10.62    52 Week High
Open $10.86    52 Week Low
Day High $11.07    P/E N/A 
Day Low $10.47    EPS
Volume 468,662